The Atlantic
- Thread starter Nopenada
- Start date
- Status
Waterslither
GLP-1 Novice 🚫No Source Discussion🚫
It’s frustrating watching major media outlets write dramatic articles about “shady” weight loss drug markets while barely touching the real reason these markets exist. Not all people are turning to alternatives because they want to be reckless. Many are doing it because medications like Ozempic and Zepbound are insanely expensive, insurance companies keep denying coverage, and regular people are being priced out of options that could genuinely help them. Meanwhile, Eli Lilly has sued the FDA over whether Reta should be classified as a drug or a biologic, wasting god knows how much money on lawsuits while essentially trying to create a monopoly over a life changing medication for many. At some point, the conversation has to stop blaming desperate patients and start asking why the official system keeps making access so difficult.
Camlbacker
GLP-1 Apprentice
You should write a letter to the Atlantic stating exactly this. They do some solid reporting on other subjects, and there is a lot of potential for social good through a more honest discussion of peptides and the profound shortcomings of American health care more broadly.Waterslither said:
mybodyisasewer
GLP-1 Apprentice
I did. Laws aren't stopping me, all the panic and pearl clutching is pointless because people are gonna do what they do. Why is everyone so worried about others' business? Why can't I be reckless?Waterslither said:
This actually hits close to home because I have 2 friends on tirz and I suspect one of them is going to get kicked off coverage very soon. I don't know that for a fact, and I have not warned her about this, and she might already be aware of this risk. But when it happens, is it my place to say anything? Like, would it be weird to say "Hey sorry your favorite drug is gone you wanna buy it from me?"Waterslither said:
"Meanwhile, Eli Lilly has sued the FDA over whether Reta should be classified as a drug or a biologic, wasting god knows how much money on lawsuits while essentially trying to create a monopoly over a life changing medication for many."
This is just the tip of the iceberg. Can you imagine how hard they would wring us if they cured cancer? Baldness? Cavities?
And mainstream media does this over and over again. Almost all the articles that attempt to "explain" the grey market completely leave out the hurdles involved and inflated costs to actually get these life-changing medications. The common thesis, is "Well, they're available, so all you're doing is stealing from Big Pharma". WRONG. I tried to give them my money, but it was never enough! The middleman PBM's have the insurance market wrapped up, and BP is perfectly happy with that. Even buying direct is still a fortune. When the healthcare system in the US is completely broken, how do you unbreak it? You go grey market and here we all are. How are they not getting that message?Waterslither said:
Think about the completely insane amount of money that research organizations have been gifted over the last 40 years to find a cure for cancer. All the walk-a-thons, all the multitude of fund raisers all over the country. And yet the only thing we have to show for it is treatments that just as often cause a secondary cancer while shrinking the first? Total racket.CMA Pooky said:
Exactly! That's why I moved overseas as the cost of Meds and Healthcare is so much cheaper outside of the States. I got tired of the greed of Big Pharma and the Insurance Industrial Complex!Chili777 said:
Retract8740
GLP-1 Apprentice
That's why I'm still using name brand Mounjaro. I'm sure Japan is more expensive than other places in Asian, but I'm getting my tirz for ~$180 USD/month out of pocket. After my insurance reimburses me, it comes out to ~$18 USD/month.CMA Pooky said:
I can't wait till Reta gets approved and makes it to market here.
indolent
GLP-1专家
- Member Since
- Mar 13, 2025
- Posts
- 30
- Likes Received
- 0
And Japan's potential market is miniscule, leading to lower efficiency for EL's marketing costs. In the USA, OTOH, 75% of all adults are potential lifetime (life of patent) paying customers.Retract8740 said:
USA prices should be WAY lower than Japan's. It's not as if there are shipping/storage/distribution/supply-demand logistics that would impact expenses.
I scratch my head when people solely blame Big Insurance rather than solely blaming Big Pharma, who set the pricing.
Thank gods for Big Bella.
Smiter
New member
There's a difference?indolent said:
Yes. Big Pharma does the R&D for the drugs and then think that entitles them to make billions on drugs that cost a few cents to manufacture, even though tax payer dollars are used to subsidize the R&D in the first place.Smiter said:
Big insurance doesn’t want to pay out any of the premiums they collect and so simply chooses to treat overly expensive life-saving medications as “elective” whenever they are pretty sure they can get away with it.
Smiter
New member
It's deeper than that...Most elites have their fingers in multiple pies and with Vanguard and blackrock, the runners of most firms tend to overlap. So while company name and operating market might differ, the controllers would likely be the same.Nopenada said:
I believe it. Like Amazon potentially pulling syringes from their site all of the sudden. Didn’t care what IV drug users were doing with them. But gotta look out for their buddies at EL and make sure it is as difficult as possible to use grey GLP1s, even as the FDA relaxes the rules on other peptides.Smiter said:
spanky2026
GLP-1 Enthusiast
You're only allowed to be reckless if it doesn't impact corporate profitsmybodyisasewer said:
Bioexplorer
GLP-1 Apprentice
Don't let the Government off the hook when assigning blame. The antiquated FDA drug approval process certainly contributed to the high cost of pharmaceuticals in this country.
- Status
